Ventricular Tachycardia Market to Hit $22.28 Billion by 2032, at a CAGR of 5.3%, says Coherent Market Insights

The Global Ventricular Tachycardia Market is estimated to be valued at USD 15.52 Bn in 2025 and is expected to reach USD 22.28 Bn by 2032, reflecting a compound annual growth rate (CAGR) of 5.3% from ...

Milestone Pharmaceuticals Inc.: Milestone Pharmaceuticals Announces U.S. Availability of CARDAMYST (etripamil) Nasal Spray, the First and Only FDA-Approve…

CARDAMYST is now conveniently available to patients through retail pharmaciesNational sales force hired with promotional ...
Android

Comparing Streaming Live TV Channels – December 2025

Summary: Here’s the latest channel lineups for each streaming live TV service. There are quite a few streaming Live TV services out there, and each one has a different channel lineup. This can make ...
The Scientist

Glutamatergic Synapses Act as a Hub for Intellectual Disability

Researchers are uncovering how disrupted glutamatergic synapses drive diverse forms of intellectual disability, revealing new ...